NIPSNAP3B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.976600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.729600E-01
Normal-vs-Stage2
1.795010E-03
Normal-vs-Stage3
1.763440E-01
Normal-vs-Stage4
2.025600E-01
Stage1-vs-Stage2
2.830600E-01
Stage1-vs-Stage3
1.916580E-01
Stage1-vs-Stage4
6.666000E-01
Stage2-vs-Stage3
6.179400E-01
Stage2-vs-Stage4
3.557200E-01
Stage3-vs-Stage4
1.284010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.023600E-02
Normal-vs-AfricanAmerican
1.323420E-01
Normal-vs-Asian
2.393900E-02
Caucasian-vs-AfricanAmerican
7.788600E-01
Caucasian-vs-Asian
4.015000E-01
AfricanAmerican-vs-Asian
4.481400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.423600E-03
Normal-vs-Female
2.952100E-02
Male-vs-Female
3.496200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.491000E-01
Normal-vs-Age(41-60Yrs)
5.332500E-02
Normal-vs-Age(61-80Yrs)
4.703900E-03
Normal-vs-Age(81-100Yrs)
1.599580E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.850400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.016600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.572100E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.291200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.802200E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.360400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.498600E-03
Normal-vs-Daily Drinker
6.817100E-03
Normal-vs-Weekly Drinker
2.068800E-01
Normal-vs-Occasional Drinker
1.696200E-02
Normal-vs-Social Drinker
3.043000E-01
Non Drinker-vs-Daily Drinker
6.177000E-01
Non Drinker-vs-Weekly Drinker
8.326600E-01
Non Drinker-vs-Occasional Drinker
7.661200E-01
Non Drinker-vs-Social Drinker
3.240200E-01
Daily Drinker-vs-Weekly Drinker
8.033200E-01
Daily Drinker-vs-Occasional Drinker
8.823000E-01
Daily Drinker-vs-Social Drinker
2.216400E-01
Weekly Drinker-vs-Occasional Drinker
9.335800E-01
Weekly Drinker-vs-Social Drinker
2.742600E-01
Occasional Drinker-vs-Social Drinker
2.702400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.741190E-01
Normal-vs-Grade 2
5.413600E-02
Normal-vs-Grade 3
8.198400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.721600E-01
Grade 1-vs-Grade 3
1.202620E-01
Grade 1-vs-Grade 4
1.741190E-01
Grade 2-vs-Grade 3
1.761390E-01
Grade 2-vs-Grade 4
5.413600E-02
Grade 3-vs-Grade 4
8.198400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.837900E-03
Normal-vs-NonDiabetic
7.220600E-03
Diabetic-vs-NonDiabetic
7.226400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.817700E-03
Normal-vs-NoPancreatitis
6.661500E-03
Pancreatitis-vs-NoPancreatitis
4.383800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.014500E-02
Normal-vs-N1
1.319510E-03
N0-vs-N1
3.103200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.023230E-01
Normal-vs-TP53-NonMutant
8.512300E-02
TP53-Mutant-vs-TP53-NonMutant
9.60810000000256E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
